Greiner Bio-One International GmbH
Greiner Bio-One specializes in the development, production and distribution of high-quality plastic laboratory products. The company is a technology partner for hospitals, laboratories, universities, research institutes, and the diagnostic, pharmaceutical and biotechnology industries. With the rapid development of the VACUETTE virus stabilization tube and an intense focus upon research and laboratory products of relevance to COVID-19, Greiner Bio-One is making a key contribution to the conquest of the pandemic. The careful management of production capacity and close cooperation with our customers constitute the basis for an extremely successful business picture.
Find locations served, office locations
- Business Type:
- Industry Type:
- Laboratory Equipment
- Market Focus:
- Globally (various continents)
This company also provides solutions for other industrial applications.
Please, visit the following links for more info:
Diagnostics specializes in the development of molecular-biological analysis methods. The field of DNA array applications ranges from human diagnostics to food technology.
Our Core Values
Our company is a global player. With a workforce of around 2,300, 28 branches and numerous sales partners, our presence spans more than 100 countries.
Our expertise lies in the development of products for clinical diagnostics, the pharmaceutical and diagnostics industries and biotechnology. This is a market that is growing with the global population, longer life expectancies and scientific advances.
Our research department develops innovative products and system solutions. Its work is geared towards the needs of our markets and is carried out in close collaboration with our cooperation partners.
Our products are innovative, efficient and of high quality, thereby complying with our customers' requirements.
Our growth is based on close and long-term cooperation with our dealers and strategic partners.
Our goal is healthy and sustainable growth. The long-term prospect of success always lies at the heart of our strategies.
Our employees are responsible for the company's success. A corporate culture geared towards teamwork and motivation, together with a broad spectrum of training and further development measures provide solid foundations for increasing our employees' knowledge, skills, expertise and long-term dedication.
Facts and Figures
In 2019, Greiner Bio-One employed a global workforce of 2,320 at 28 locations in 20 countries. The company achieved sales revenues of EUR 509 million, which represented growth of 8 percent over the preceding year (2018: EUR 473 million), and passed the EUR 500 million mark for the first time.
Therefore, in spite of a challenging market environment, the successful business trend of recent years was maintained. Moreover, extensive increases in capacity enabled the use of a range of fresh potential and new customers were also obtained. In particular, market shares were gained in the USA and Latin America and positive currency effects emanating from the exchange rates for the US dollar and Japanese yen generated additional momentum. The business result also benefited from the fall in raw material prices, which was particularly notable in the second half-year.
Greiner Bio-One looks to the coming year with confidence. New large-scale orders that come into effect in 2020, as well as continuous market growth, permit the next twelve months to be viewed with great optimism. The strong network of international production and sales locations, as well as the conclusion of current location and capacity enlargement will once again secure the supply of international customers with products of the highest quality.